Why the study?
Does preadmission statin use reduce one-year mortality in patients in intensive care?
Population
Patients in intensive care
Comparison
Preadmission statin use vs Non-users of statins
Design
Cohort
Follow-up
One year
Authors
Loading...
Preadmission statins may improve ICU survival; hypothesis-generating and should not change practice without RCTs.
Does preadmission statin use reduce one-year mortality in patients in intensive care?
Preadmission statin use is associated with a reduced risk of one-year mortality among intensive care patients, though residual confounding remains a possibility.
Christensen et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: